Zhu et al.
2021
Clinical characteristics and prognosis of ovarian clear cell carcinoma: a 10-year retrospective study
JP5750152B2
(ja )
2015-07-15
肝細胞癌と関連するシグネチャ遺伝子を利用する検査方法、及び該方法に用いられるアレイ又はキット
Nel et al.
2013
Individual profiling of circulating tumor cell composition and therapeutic outcome in patients with hepatocellular carcinoma
Banys-Paluchowski et al.
2018
The clinical relevance of serum vascular endothelial growth factor (VEGF) in correlation to circulating tumor cells and other serum biomarkers in patients with metastatic breast cancer
Korse et al.
2015
Multicenter evaluation of a new progastrin-releasing peptide (ProGRP) immunoassay across Europe and China
McAndrew et al.
2021
Effects of systemic inflammation on relapse in early breast cancer
Hetland et al.
2012
HMGA2 protein expression in ovarian serous carcinoma effusions, primary tumors, and solid metastases
Li et al.
2016
Association between Ki67 index and clinicopathological features in colorectal cancer
Chen et al.
2018
eEF1A1 overexpression enhances tumor progression and indicates poor prognosis in hepatocellular carcinoma
CN102625849B
(zh )
2014-09-24
侦测致死细胞的方法与材料及其应用
Chen et al.
2017
Chromobox homolog 2 protein: A novel biomarker for predicting prognosis and Taxol sensitivity in patients with breast cancer
Gonzalez-Roibon et al.
2013
The role of GATA binding protein 3 in the differential diagnosis of collecting duct and upper tract urothelial carcinomas
Yan et al.
2018
A novel rapid quantitative method reveals stathmin‐1 as a promising marker for esophageal squamous cell carcinoma
Ng Kee Kwong et al.
2018
Expression of PD‐L1 correlates with pleomorphic morphology and histological patterns of non‐small‐cell lung carcinomas
Fodor et al.
2019
Angiogenesis of hepatocellular carcinoma: An immunohistochemistry study
Wu et al.
2019
Clinical and prognostic implications of pretreatment albumin to C-reactive protein ratio in patients with hepatocellular carcinoma
EP2704745A1
(en )
2014-03-12
Methods of developing a prognosis for pancreatic cancer and predicting responsiveness to cancer therapeutics
Zhang et al.
2022
Lymphocyte to C-reactive protein ratio could better predict the prognosis of patients with stage IV cancer
Laloglu et al.
2017
Serum endocan levels in endometrial and ovarian cancers
Shim et al.
2013
Half-life of serum alpha-fetoprotein: an early prognostic index of recurrence and survival after hepatic resection for hepatocellular carcinoma
Ni et al.
2016
Detection of circulating tumour cells may add value in endometrial cancer management
Sugai et al.
2017
Vascular invasion and stromal S100A4 expression at the invasive front of colorectal cancer are novel determinants and tumor prognostic markers
Fujikura et al.
2021
Downregulation of 5‐hydroxymethylcytosine is an early event in pancreatic tumorigenesis
Wang et al.
2014
The combination of HTATIP2 expression and microvessel density predicts converse survival of hepatocellular carcinoma with or without sorafenib
Byeon et al.
2018
Long-term prognostic impact of osteopontin and Dickkopf-related protein 1 in patients with hepatocellular carcinoma after hepatectomy